Reid Hoffman is stepping down from Microsoft's board after a decade to focus on Manus, his AI drug discovery startup. Hoffman joined Microsoft's board following the $26.2B LinkedIn acquisition in 2016 and was present for key moves including the $1B OpenAI investment and the $650M Inflection AI acqui-hire. Manus, co-founded by Hoffman and led by CEO Dr. Siddhartha Mukherjee, has raised over $50M in seed funding and is working on AI that can surpass human creativity in chemistry, particularly for cancer research.
185 Impressions